IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
Lists of datasets, publishers, markets, and tickers. Market data: ticker snapshots, time series, trades, and technical indicators. Data from specific datasets such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results